IRadimed Corporation IRMD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.51M | 5.22M | 5.82M | 6.44M | 5.58M |
| Total Depreciation and Amortization | 412.00K | 410.00K | 455.00K | 380.70K | 383.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 750.00K | 656.00K | 602.00K | 3.05M | 803.00K |
| Change in Net Operating Assets | -671.00K | -344.00K | 1.42M | -3.95M | 223.00K |
| Cash from Operations | 7.00M | 5.94M | 8.29M | 5.92M | 6.99M |
| Capital Expenditure | -130.00K | -185.00K | -403.00K | -294.20K | -1.14M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -82.00K | -258.00K | -66.00K | -122.20K | -126.00K |
| Cash from Investing | -212.00K | -443.00K | -469.00K | -416.40K | -1.26M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -19.00K | -234.00K | -50.00K | -2.32M | -30.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.56M | -2.56M | -2.56M | -8.55M | -2.16M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.58M | -2.79M | -2.61M | -10.87M | -2.19M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 1.00K |
| Net Change in Cash | 4.21M | 2.71M | 5.22M | -5.37M | 3.53M |